Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2286
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAltinbas, A.-
dc.contributor.authorBayrak, A.-
dc.contributor.authorBayrak, T.-
dc.contributor.authorBektas, O.-
dc.contributor.authorCanakci, E.-
dc.contributor.authorKaratas, A.-
dc.contributor.authorTurkmen, E.-
dc.date.accessioned2022-08-17T05:27:14Z-
dc.date.available2022-08-17T05:27:14Z-
dc.date.issued2018-
dc.identifier.urihttp://doi.org/10.4149/BLL_2018_102-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2286-
dc.description.abstractINTRODUCTION AND OBJECTIVE: IMA and MPO are elevated in serum in case of end-stage renal disease. Epicardial fat tissue thickness has been considered an indicator for cardiovascular diseases recently. The present study was aimed to examine the relationship of epicardial fat tissue thickness (EFTT) with IMA and MPO levels in patients with CKD. MATERIALS AND METHODS: Predialysis CKD patients admitted to the Nephrology outpatient clinic, patients on haemodialysis and healthy volunteers were included, 111 patients were in the study. EFTT measurement was performed with the transthoracic view using an ECHO device. RESULTS: The analysis conducted among the groups in terms of IMA, MPO levels, and EFTT revealed a statistically significant difference (p < 0.001). It was determined to be the lowest in the healthy volunteers, slightly increased in the pre-dialysis group whereas it was quite high in the haemodialysis group. According to the correlation test performed, we observed that IMA, MPO levels, and EFTT were found to be highly correlated to progression of CKD. CONCLUSION: We believe that we have introduced three novel follow-up parameters, such as: IMA, MPO, EFTT to literature for the follow-up of CKD. As the levels of IMA MPO and EFTT increase, the severity of CKD increases (Tab. 4, Fig. 1, Ref. 25). Text in PDF www.elis.sk.en_US
dc.language.isoengen_US
dc.publisherCOMENIUS UNIV, SCH MEDICINE, SPITALSKA 24, BRATISLAVA I, SK-813 72, SLOVAKIAen_US
dc.relation.isversionof10.4149/BLL_2018_102en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectchronic kidney disease; epicardial fat tissue thickness; ischemia-modified albumin; myeloperoxidaseen_US
dc.titleRelationship of epicardial fat tissue thickness with oxidant biomarkers in chronic kidney diseaseen_US
dc.typearticleen_US
dc.relation.journalBRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTYen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0001-9095-6054en_US
dc.contributor.authorID0000-0003-2093-9229en_US
dc.identifier.volume119en_US
dc.identifier.issue9en_US
dc.identifier.startpage566en_US
dc.identifier.endpage571en_US
Appears in Collections:Dahili Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.